Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


12 Items
Title  Creator  Group name  Publishing year 
Learning curve for robotic-assisted total mesorectal excision: a multicentre, prospective study Arquillière et al. EquipeCTCS 2023-09
[Clinical trials in Radiation Oncology: Methodologic approach] Gourgou and Azria EquipeJPP 2022-10
Tumour and normal tissue radiosensitivity Lapierre et al. EquipeJPP 2022-02-01
[Predictive assays for responses of tumors and normal tissues in radiation oncology] Riou et al. EquipeAP Aug 23, 2019
[Individual modification of the dose, volume and fractionation of breast radiotherapy] Bourgier et al. EquipeJPP 2019-10
Early MRI predictors of disease-free survival in locally advanced rectal cancer from the GRECCAR 4 trial Nougaret et al. EquipeMY Aug 22, 2019
Prospective medical analysis of radiation therapist image repositioning during image-guided radiotherapy Lauche et al. EquipeNB Feb 2018
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer Bascoul-Mollevi et al. EquipeMY 10 2017
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial Azria et al. EquipeAP Dec 2015
Concurrent or sequential letrozole with adjuvant breast radiotherapy: Final results of the CO-HO-RT phase II randomized trial Bourgier et al. EquipeAP Dec 17, 2015
Clinical Development Strategies and Outcomes in First-in-Human Trials of Monoclonal Antibodies Tosi et al. EquipeCG Jul 1 2015
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France Houede et al. EquipeCG 2015
12 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés